Analysis of Anxiety Levels in End-Stage Kidney Disease Pa-tients Under Dialysis Therapy
DOI:
https://doi.org/10.32528/ias.v3i1.473Keywords:
Anxiety, End Stage Renal Disease, DialisysAbstract
End-stage renal disease has a profound impact on both the physiological and psychological aspects of patients. The consequences of end-stage renal disease extend to anxiety, influenced by the symptoms encountered and the side effects resulting from hemodialysis therapy, which, in turn, affects life expectancy and adherence to disease management. This study aims to investigate anxiety levels in individuals with chronic kidney disease undergoing dialysis. This descriptive analytic study involved a total of 45 respondents undergoing hemodialysis therapy at Jember Klinik Hospital. The instruments utilized included an observational form and the Hamilton Anxiety Rating Scale. The findings revealed varying levels of anxiety, with severe anxiety at 33.3%, moderate anxiety at 31.1%, mild anxiety at 22.2%, and no anxiety at 13.3%. In the anxiety variable, among the 14 observation items on the HARS instrument, the most pronounced disturbances were observed in tension, depression, cardiovascular symptoms, and respiratory symptoms. Anxiety remains a prevalent psychological symptom among many end-stage renal patients. Strategies should be implemented to mitigate anxiety in patients, thereby improving their quality of life and reducing mortality
Downloads
References
S. De Rosa, J. Raposo, A. Protectora Dos Diabeticos De Portugal, S. Grima, N. Chaiyakun-apruk, and C. Kitiyakara, “The hidden financial catastrophe of chronic kidney disease under universal coverage and Thai ``Peritoneal Dialysis First Policy’’,” 2022. [Online]. Available: www.thaiclinicaltrials.org
Kemenkes RI, “Hasil Riskesdas 2018,” Jakarta, 2018. Accessed: Dec. 29, 2021. [Online]. Available: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf
Kemenkes, “Pedoman Nasional Pelayanan Kedokteran Tata Laksanan Penyakit Ginjal Tahap Akhir,” 2017.
J. Himmelfarb, R. Vanholder, R. Mehrotra, and M. Tonelli, “The current and future landscape of dialysis,” Nature Reviews Nephrology, vol. 16, no. 10. Nature Research, pp. 573–585, Oct. 01, 2020. doi: 10.1038/s41581-020-0315-4.
K. Abdel-Kader, M. L. Unruh, and S. D. Weisbord, “Symptom Burden, Depression, and Quality of Life in Chronic and End-Stage Kidney Disease,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 6, pp. 1057–1064, Jun. 2009, doi: 10.2215/CJN.00430109.
J. Fioran Elek et al., “Pengaruh Lama Hemodialisa Dan Tingkat Kecemasan Terhadap Kepatuhan Pasien Hemodialisa Dalam Program Restriksi Cairan,” 2022.
S. D. Cohen, D. Cukor, and P. L. Kimmel, “Anxiety in Patients Treated with Hemodialysis,” Clinical Journal of the American Society of Nephrology, vol. 11, no. 12, pp. 2250–2255, Dec. 2016, doi: 10.2215/CJN.02590316.
L. Rosyanti, I. Hadi, I. Antari, and S. Ramlah, “Faktor Penyebab Gangguan Psikologis pada Penderita Penyakit Ginjal Kronis yang menjalani Hemodialisis: Literatur Reviu Naratif,” Health Information : Jurnal Penelitian, vol. 15, no. 2, p. e1102, Aug. 2023, doi: 10.36990/hijp.v15i2.1102.
W. Dziubek et al., “Assessment of depression and anxiety in patients with chronic kidney disease and after kidney transplantation—a comparative analysis,” Int J Environ Res Public Health, vol. 18, no. 19, Oct. 2021, doi: 10.3390/ijerph181910517.
L. Juwita and I. R. Kartika, “Pengalaman Menjalani Hemodialisa Pada Pasien Gagal Ginjal Kronis,” Jurnal Endurance, vol. 4, no. 1, p. 97, Mar. 2019, doi: 10.22216/jen.v4i1.3707.
S. Rahman and R. Pradido, “The anxiety symptoms among chronic kidney disease patients who undergo hemodialysis therapy,” International Journal of Public Health Science (IJPHS), vol. 9, no. 4, pp. 181–185, 2020, doi: 10.11591/ijphs.v9i4.
S. Hallit et al., “Validation of the Hamilton Anxiety Rating Scale and State Trait Anxiety Inventory A and B in Arabic among the Lebanese population,” Clin Epidemiol Glob Health, vol. 8, no. March, pp. 1104–1109, 2020, doi: 10.1016/j.cegh.2020.03.028.
D. B. Clark and J. E. Donovan, “Reliability and validity of the Hamilton Anxiety Rating Scale in an adolescent sample.,” J Am Acad Child Adolesc Psychiatry, vol. 33, no. 3, pp. 354–360, 1994, doi: 10.1097/00004583-199403000-00009.
P. Gadia, A. Awasthi, S. Jain, and G. Koolwal, “Depression and anxiety in patients of chron-ic kidney disease undergoing haemodialysis: A study from western Rajasthan,” J Family Med Prim Care, vol. 9, no. 8, p. 4282, 2020, doi: 10.4103/jfmpc.jfmpc_840_20.
H. K. Aggarwal, D. Jain, G. Dabas, and R. K. Yadav, “Prevalence of Depression, Anxiety and Insomnia in Chronic Kidney Disease Patients and their Co-Relation with the Demo-graphic Variables,” Prilozi, vol. 38, no. 2, pp. 35–44, Sep. 2017, doi: 10.1515/prilozi-2017-0020.
S. T. Shafi and T. Shafi, “A comparison of anxiety and depression between pre-dialysis chronic kidney disease patients and hemodialysis patients using hospital anxiety and depres-sion scale,” Pak J Med Sci, vol. 33, no. 4, pp. 876–880, Jul. 2017, doi: 10.12669/pjms.334.12656.
R. D. Kandou, B. F. Tokala, L. F. J. Kandou, and A. E. Dundu, “Hubungan Antara Lama Menjalan Hemodialisis Dengan Tingkat Kecemasan Pada Pasien Dengan Gagal Ginjal Kronis di RSUP ProfDr. R. D. Kandou Manado,” 2015.
S. M. A. Dijkstra-Kersten, K. E. M. Biesheuvel-Leliefeld, J. C. van der Wouden, B. W. J. H. Penninx, and H. W. J. van Marwijk, “Associations of financial strain and income with de-pressive and anxiety disorders,” J Epidemiol Community Health (1978), vol. 69, no. 7, pp. 660–665, Jul. 2015, doi: 10.1136/jech-2014-205088.
H. Mosleh, M. Alenezi, S. Al johani, A. Alsani, G. Fairaq, and R. Bedaiwi, “Prevalence and Factors of Anxiety and Depression in Chronic Kidney Disease Patients Undergoing Hemodi-alysis: A Cross-sectional Single-Center Study in Saudi Arabia,” Cureus, Jan. 2020, doi: 10.7759/cureus.6668.
G. S. Adi and E. P. Utomo, “Frailty among hemodialysis patients,” MEDISAINS, vol. 20, no. 1, p. 12, Apr. 2022, doi: 10.30595/medisains.v20i1.12374.
N. Isnaini, R. Sukma, and H. D. Aprilina, “The Influence of Family Support on Self Efficacy of Chronic Kidney Disease,” 2021.
S. Alshelleh et al., “Prevelance of depression and anxiety with their effect on quality of life in chronic kidney disease patients,” Sci Rep, vol. 12, no. 1, Dec. 2022, doi: 10.1038/s41598-022-21873-2.
B. Yucens et al., “The association between hope, anxiety, depression, coping strategies and perceived social support in patients with chronic kidney disease,” Dusunen Adam - The Jour-nal of Psychiatry and Neurological Sciences, vol. 32, no. 1, pp. 43–51, 2019, doi: 10.14744/DAJPNS.2019.00006.
S. Chirakarnjanakorn, S. D. Navaneethan, G. S. Francis, and W. H. W. Tang, “Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considera-tions,” Int J Cardiol, vol. 232, pp. 12–23, Apr. 2017, doi: 10.1016/j.ijcard.2017.01.015.
A. F. Palamidas et al., “Impact of Hemodialysis on Dyspnea and Lung Function in End Stage Kidney Disease Patients,” Biomed Res Int, vol. 2014, pp. 1–10, 2014, doi: 10.1155/2014/212751.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
